Close Menu


A US Appeals Court overturned a lower court's decision in favor of Life Technologies predecessor firm Applera, clearing the way for it to pursue a claim for "substantial damages."

The latest suit alleges that the BD MAX system infringes upon several patents owned by Gen-Probe related to its Tigris molecular diagnostics blood-screening system

As part of its request for dismissal, MIT admitted no wrongdoing, but agreed to be bound by any court ruling against the case's other defendants, the Whitehead Institute for Biomedical Research and the University of Massachusetts Medical School.

A Pennsylvania court has dismissed an appeal of an earlier ruling that found the company did not owe its former CEO $20 million.

Transgenomic has claimed in a suit that Power3 has wrongly terminated a licensing deal between the firms, while engaging in fraud and slander.

The case centered on former Agilent employees who went to work for AMT, and whom Agilent accused of misappropriating trade secrets.

Celera's BHL subsidiary had filed a suit last month against a competing firm and former employees for conspiring to steal clients and employees. The parties have been discussing a possible settlement as they head toward a trial, currently scheduled for May.

Roche filed the suit yesterday in response to DxS' efforts to terminate a molecular diagnostics distribution deal.

In what could be a "far reaching" case, a judge hears arguments about humanity and biotechnology today but is not ready to rule.

The matter is of particular importance since UMass is the only one of the four organizations to which the IP is assigned to have licensed it to companies other than Alnylam.


Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.